Cancer

Removable ‘cloak’ for nanoparticles helps them target tumorsNew MIT particles could be used to deliver cancer drugs to nearly any type of tumor.

Understanding why lung cancer spreadsMIT biologists pinpoint a genetic change that helps tumors move to other parts of the body.

Catching cancer with carbon nanotubesNew device to test blood can spot cancer cells, HIV on the fly

In vivo systems biologyUsing computer models, systems biologists can predict complicated behavior of cells in living animals

The past, present and future of cancerResearchers gather to discuss the state of their field and the potential for new treatments.

David H. Koch Institute for Integrative Cancer Research fetedMIT celebrates the official opening of the institute's new building.

Going with the flowNew 3-D microfluidic system offers greater control over production of drug-delivering nanoparticles.

Exploiting cancer cells' weaknessesTeam identifies potential drugs that enhance stress caused by too many chromosomes.

Nano-sized vaccinesNew MIT nanoparticles could lead to powerful vaccines for HIV and other diseases.

Detecting whether a heart attack has occurredNew implantable sensor finds telltale signs; technology could also be adapted to monitor cancer and other diseases.

Vander Heiden wins cancer innovation awardAwarded $450,000 grant over three years

Putting up a struggle against cancerBlood-vessel cells can combat aggressive tumors, helping to prevent them from spreading through the body, new study finds.

Delivering a potent cancer drug with nanoparticles can lessen side effectsThe new nanoparticle, which delivers the drug in a form activated when it reaches its target, also treats tumors more effectively than the unadorned drug in mice.

A new approach to bladder-disease treatmentImplanted device can release slow, steady dose of medicine over extended period, removing the need for repeated procedures.

Timing is everything for cancer protein p53Biologists find that restoring the gene for p53 can slow the spread of advanced lung tumors, but doesn’t help early-stage cancers.

Slideshow: the Koch Institute transforms East Campus environsCompletion of cancer-research building opens green space for community use and creates vibrant streetscape.

Direct deliveryCancer scientists believe nanoparticles could accurately target tumors, avoiding side effects.

Using the body’s own defenses to combat cancerBy engineering T cells to attack tumors, researchers hope to add a new weapon to their cancer-fighting arsenal.

Turning off cancer genesRNA interference holds much promise as a cancer treatment, but technical challenges remain.

A better way to target tumorsIn spite of slow progress toward targeting cancer drugs to individual patients, hope remains.

A new target for cancer drugsShutting down an enzyme that responds to DNA damage could boost the effects of traditional chemotherapy.

More than just a pretty flowerMIT chemists engineer the periwinkle plant to produce compounds that could become more effective cancer drugs.

Cancer’s hiding spots revealedDiscovery that tumor cells can escape from chemotherapy could lead to new treatments that prevent relapse.

New Koch Institute building to open soonResearchers will start moving into the 365,000-square-foot building next week.

MIT Medical promotes employee mammogramsNo referral or copay for female employees between 40 and 70 who are enrolled in any MIT-sponsored health-insurance plan.

Surprising similarities between human and zebrafish tumorsNew finding that tumor cells in both species have too many chromosomes could help pinpoint genes that drive cancer development.

New nanoparticles could improve cancer treatmentParticles can deliver a combination of chemotherapy drugs directly to prostate-cancer cells.

Getting bacteria to do a plant’s jobResearchers engineer microbes for low-cost production of precursor of anticancer drug Taxol and other pharmaceuticals.

An unexpected twist in cancer metabolismA cancer-cell quirk could be exploited to develop new drugs that starve tumors.